Razo 20 Tablet is used for the treatment of stomach and intestinal ulcers (gastric and duodenal ulcers), reflux esophagitis, or gastroesophageal reflux disease (GERD). It works by reducing the amount of acid made by your stomach and thus relieves your symptoms.

Razo 20 MG Tablet is an anti-ulcer medicine that contains Rabeprazole. It is used to treat acid-related conditions of the stomach and intestine such as acid reflux, peptic ulcers, and some other stomach conditions associated with excessive acid production.

Razo 20mg Tablet is a medicine that reduces the amount of acid produced in your stomach. It is used in the treatment of acid-related diseases of the stomach and intestine such as acid reflux, peptic ulcer disease, and Zollinger-Ellison syndrome. It provides relief from symptoms and promotes healing.

Feb 3, 2020 · Razo 20 tablet is used to relieve acidity and heartburn in conditions such as stomach and intestinal ulcers, gastroesophageal reflux disease (GERD) and Zollinger-Ellison Syndrome.

Razo 20 Tablet is used to treat acid reflux, peptic ulcer disease. Buy Razo 20 Tablet online at Truemeds and get free delivery. Know Razo 20 Tablet benefits & specifications.

Razo 20 MG Tablet is prescribed for the short-term treatment of erosive esophagitis associated with gastroesophageal diseases (GERD). It is also helpful in treating peptic ulcers, acid reflux, and Zollinger-Ellison syndrome.

Razo 20 Tab is used to treat Gastroesophageal reflux disease (Acid reflux), Treatment of Peptic ulcer disease. View Razo 20 Tab (strip of 15 tablets) price, uses, benefits, side effects, composition, precautions, warnings. Self-pickup or buy genuine products online at …

Razo 20 mg Tablet is indicated for the treatment of gastroesophageal reflux disease, gastric ulcer, and Zollinger-Ellison syndrome. Each enteric-coated Razo 20 mg Tablet contains Rabeprazole Sodium 20 mg.

Jan 7, 2025 · Razo Sodium is an antiulcerant drug in the class of Proton Pump Inhibitors. Razo Sodium is a substituted benzimidazole which suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase enzyme at the secretory surface of the gastric parietal cell.